ZA200801402B - Use of 2-phenyl-L, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy - Google Patents

Use of 2-phenyl-L, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy

Info

Publication number
ZA200801402B
ZA200801402B ZA200801402A ZA200801402A ZA200801402B ZA 200801402 B ZA200801402 B ZA 200801402B ZA 200801402 A ZA200801402 A ZA 200801402A ZA 200801402 A ZA200801402 A ZA 200801402A ZA 200801402 B ZA200801402 B ZA 200801402B
Authority
ZA
South Africa
Prior art keywords
ethanediol
carbamates
epilepsy
phenyl
treating epileptogenesis
Prior art date
Application number
ZA200801402A
Other languages
English (en)
Inventor
Roy E Twyman
Zhao Boyu
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37637731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200801402(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA200801402B publication Critical patent/ZA200801402B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA200801402A 2005-07-12 2008-02-11 Use of 2-phenyl-L, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy ZA200801402B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69862505P 2005-07-12 2005-07-12

Publications (1)

Publication Number Publication Date
ZA200801402B true ZA200801402B (en) 2009-10-28

Family

ID=37637731

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801402A ZA200801402B (en) 2005-07-12 2008-02-11 Use of 2-phenyl-L, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy

Country Status (16)

Country Link
US (1) US20070021501A1 (https=)
EP (1) EP1906946A2 (https=)
JP (1) JP2009501223A (https=)
KR (1) KR20080028485A (https=)
CN (1) CN101309680A (https=)
AR (1) AR054550A1 (https=)
AU (1) AU2006269462A1 (https=)
BR (1) BRPI0613010A2 (https=)
CA (1) CA2615127A1 (https=)
EA (1) EA200800295A1 (https=)
EC (1) ECSP088172A (https=)
IL (1) IL188728A0 (https=)
NO (1) NO20080739L (https=)
TW (1) TW200744575A (https=)
WO (1) WO2007008551A2 (https=)
ZA (1) ZA200801402B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102088990A (zh) * 2008-05-16 2011-06-08 阿尔伯维塔公司 癫痫的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2968210B1 (en) * 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
KR102481631B1 (ko) * 2015-08-24 2022-12-27 조게닉스 인터내셔널 리미티드 펜플루라민을 사용하여 레녹스-가스토 증후군을 치료하는 방법
ES3059582T3 (en) * 2016-02-29 2026-03-23 Bio Pharm Solutions Co Ltd Sulfamate derivative compounds, processes for preparing them and their uses
US20190022166A1 (en) * 2017-07-18 2019-01-24 Creative Bio-Peptides Inc. Oral anti-inflammatory peptides to treat epilepsy, seizures and cns disorders
USRE50630E1 (en) 2017-10-31 2025-10-14 Creative BioPeptides, Inc. Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain
CN109920550A (zh) * 2018-12-25 2019-06-21 天津大学 一种基于dMRI研究青少年肌阵挛性癫痫的方法
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
CN115501344A (zh) * 2022-09-29 2022-12-23 重庆医科大学 一种铁螯合剂的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
AU3304997A (en) * 1996-05-31 1998-01-05 Southern Illinois University Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
CA2360258A1 (en) * 1999-02-09 2000-08-17 Timothy L. Macdonald Felbamate derived compounds
MXPA03007717A (es) * 2001-02-27 2005-11-08 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o tratamiento de trastornos bipolares.
PL364640A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder

Also Published As

Publication number Publication date
CA2615127A1 (en) 2007-01-18
WO2007008551A3 (en) 2008-06-19
KR20080028485A (ko) 2008-03-31
BRPI0613010A2 (pt) 2010-12-14
NO20080739L (no) 2008-04-10
TW200744575A (en) 2007-12-16
EP1906946A2 (en) 2008-04-09
IL188728A0 (en) 2008-11-03
EA200800295A1 (ru) 2008-12-30
CN101309680A (zh) 2008-11-19
US20070021501A1 (en) 2007-01-25
JP2009501223A (ja) 2009-01-15
AR054550A1 (es) 2007-06-27
ECSP088172A (es) 2008-03-26
WO2007008551A2 (en) 2007-01-18
AU2006269462A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
ZA200801402B (en) Use of 2-phenyl-L, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
IL217882A0 (en) Polyurethanes, polyurethane(ureas) sulfur-containing polyurethanes and sulfer-containing polyurethane(ureas and methods of preparation
ZA200705951B (en) Hydroprocessing catalyst, preparation method thereof and use of same
EP1843835A4 (en) NOZZLE REACTOR AND METHOD OF USE
IL228770A0 (en) processes and intermediates
TWI367780B (en) Catalytic plant and process
GB0511749D0 (en) Resisting the spread of unwanted code and data
EP1931344A4 (en) DEVICES FOR TREATING VESSELS
EP1795634A4 (en) LEATHER YARN AND CORRESPONDING PROCESSING METHOD
IL190913A0 (en) Methods for the treatment of hyperhidrosis
EP1908749A4 (en) PROCESS FOR PREPARING ISOCYANATE, ISOCYANATE MADE ACCORDING TO IT AND USE OF ISOCYANATE
IL189165A0 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
GB0404656D0 (en) Treatment of spinal conditions
GB2469406B (en) Elongate band,wristwatch comprising same and watchcase
ZA200701488B (en) Plant treatment material
GB0515090D0 (en) Novel epilepsy treatment
EP1888056A4 (en) USE OF LADOSTIGIL FOR TREATING MULTIPLE SCLEROSIS
GB0402629D0 (en) Reactor and process
ZA200709024B (en) Method of well treatment and construction
GB0500451D0 (en) Hair treatment apparatus
PL1809273T3 (pl) Zastosowanie (di)karbaminianów 2-fenylo-1,2-etanodiolu do leczenia rozwoju padaczki
SG126059A1 (en) Tunable mask apparatus and process
ZA200702195B (en) Use of 2-phenyl-1,2-ethanediol (Dl) carbamates for treating epileptogenesis and epilepsy
ZA200704725B (en) Product and method of treatment
ZA200805748B (en) Compounds, screens, and methods of treatment